In this manner, EBV has evolved an elegant strategy for ensuring initial colonization followed by persistent, benign infection in the immunocompetent host, in which a sizable portion of the memory CD8+ T cell pool (~2–5%) is dedicated to maintaining EBV-specific immunosurveillance (3, 13). This evidence concerns the gene CD8A and infection.